PRELUDE THERAPEUTICS INC shareholders Q1 2023

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

PRELUDE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Cutler Group LLC / CA 2,130$120.00%
Renaissance Technologies 138,500$7890.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 34,298$195,4990.00%
GEODE CAPITAL MANAGEMENT, LLC 145,904$831,6520.00%
STATE STREET CORP 43,889$250,1670.00%
MILLENNIUM MANAGEMENT LLC 136,519$7780.00%
PRICE T ROWE ASSOCIATES INC /MD/ 284,362$1,6220.00%
NISA INVESTMENT ADVISORS, LLC 4,000$230.00%
CITIGROUP INC 70,767$403,3720.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 62,851$358,2510.00%
GOLDMAN SACHS GROUP INC 49,496$282,1270.00%
MORGAN STANLEY 141,662$807,4740.00%
BlackRock Inc. 423,028$2,411,2600.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 129,680$739,1760.00%
Daiwa Securities Group Inc. 104$10.00%
HighMark Wealth Management LLC 50$2850.00%
Cutler Group LLC / CA 600$00.00%
Point72 Middle East FZE 1,680$9,5760.00%
JPMORGAN CHASE & CO 1,394$8,0000.00%
BARCLAYS PLC 10,322$590.00%
External links

This page lists PRELUDE THERAPEUTICS INC's shareholders in Q1 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.